Placebo group

Lidocaine group

Paracetamol group

p

EVS 0

9 (15%)

47 (78.3%)

38 (63.3%)

<0.01

EVS 1

14 (23.3%)

7 (11.7%)

11 (18.3%)

<0.01

EVS 2

16 (26.7%)

5 (8.3%)

6 (10%)

<0.01

EVS 3

21 (35%)

1 (1.7%)

5 (8.3%)

<0.01

EVS > 0

(1 + 2 + 3)

51 (85%)

13 (21.7%)

22 (36.6%)

<0.01